ASC-H
Principal Investigator(s)
and HSIL. Secondly
Collaborating Institutions
we intend to compare the clinical performance of the Molecular Pap to current cervical cancer screening (traditional Pap +/- cobas® hrHPV) in a head-to-head challenge to continue the development of this molecular diagnostic.
Research Start Date
Status
Inactive